NOTICE TO DISREGARD — Avicanna Inc.
TORONTO, March 15, 2021 (GLOBE NEWSWIRE) — We are advised by Avicanna Inc. that journalists and…
TORONTO, March 15, 2021 (GLOBE NEWSWIRE) — We are advised by Avicanna Inc. that journalists and…
Anchiano shareholders approve all resolutions at shareholder meeting The merged company is expected to receive…
– Firdapse® Q4-20 Net Revenues of $31.0 Million, FY-20 Net Revenues of $119.1 Million –…
Daix (France), March 15, 2021 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical…
– Initial dose-escalation data from Phase 1 clinical trial for lead wholly owned CD47 checkpoint…
Announced Positive Phase 3 RELIEF Study Results for TNX-102 SL 5.6 mg in Fibromyalgia Interim…
CAMBRIDGE, Mass., March 15, 2021 (GLOBE NEWSWIRE) — Rubius Therapeutics, Inc. (NASDAQ: RUBY) (“Rubius”), a…
MIAMI, March 15, 2021 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ:LGVN) (“Longeveron” or the “Company”), a…
Reports Net Revenues of $95.9 Million for the Three Months Ended December 31, 2020 RANCHO…
FORT LAUDERDALE, Fla., March 15, 2021 (GLOBE NEWSWIRE) — Motus GI Holdings, Inc., (NASDAQ: MOTS)…
Agreement leverages Fulgent’s Next Generation Sequencing (“NGS”) capabilities for genomic sequencing to aid in ongoing…
Total second quarter revenue of $31.5 million increased 62% year-over-year on continued recovery and expansion…
SAN CARLOS, Calif., March 15, 2021 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a…
03_15_2021 Press Release Image Retail Display Box – Vitamin D3 Infused Tauri-Gum™ The Company’s Assembling of…
Tycoon Industrier AS has today 15 March 2021 purchased 784 280 shares in Vistin Pharma at NOK…
Saga Pure ASA has on 15 March 2021 sold 2,284,280 shares in Vistin Pharma ASA,corresponding…
MORRISTOWN, N.J., March 15, 2021 (GLOBE NEWSWIRE) — BioAegis Therapeutics Inc., a clinical stage, private…
Apabetalone Inhibits SARS-CoV-2 Infection at Levels Comparable to Approved Antiviral CALGARY, Alberta, March 15, 2021…
CAMBRIDGE, Mass., March 15, 2021 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (Nasdaq: MRSN), a clinical-stage…
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR…